Unknown

Dataset Information

0

DLL3: an emerging target in small cell lung cancer.


ABSTRACT: Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. Despite high rates of response to first-line chemotherapy and radiotherapy, patients with extensive-stage disease eventually relapse, and very few patients survive more than 5?years from diagnosis. Treatment options for recurrent or refractory disease are limited, and the treatments that do exist are associated with significant treatment-related toxicities. Delta-like ligand 3 (DLL3) is an inhibitory Notch ligand that is highly expressed in SCLC and other neuroendocrine tumors but minimally expressed in normal tissues. It is therefore being explored as a potential therapeutic target in SCLC. Here, we review the preclinical and clinical evidence for targeting DLL3 in SCLC and discuss several DLL3-specific therapies being developed for the treatment of SCLC: the antibody-drug conjugate rovalpituzumab tesirine, the bispecific T cell engager immuno-oncology therapy AMG 757, and the chimeric antigen receptor T cell therapy AMG 119.

SUBMITTER: Owen DH 

PROVIDER: S-EPMC6582566 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

DLL3: an emerging target in small cell lung cancer.

Owen Dwight H DH   Giffin Michael J MJ   Bailis Julie M JM   Smit Marie-Anne Damiette MD   Carbone David P DP   He Kai K  

Journal of hematology & oncology 20190618 1


Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. Despite high rates of response to first-line chemotherapy and radiotherapy, patients with extensive-stage disease eventually relapse, and very few patients survive more than 5 years from diagnosis. Treatment options for recurrent or refractory disease are limited, and the treatments that do exist are associated with significant treatment-related toxicities. Delta-like ligand 3 (DLL3) is an inhibitory Notch ligand t  ...[more]

Similar Datasets

| S-EPMC10290806 | biostudies-literature
| S-EPMC9722452 | biostudies-literature
| S-EPMC6992936 | biostudies-literature
| S-EPMC5534176 | biostudies-literature
| S-EPMC6501010 | biostudies-literature
| S-EPMC6498593 | biostudies-literature
| S-EPMC6877464 | biostudies-literature
| S-EPMC6482588 | biostudies-literature
| S-EPMC7817862 | biostudies-literature
| S-EPMC9632312 | biostudies-literature